Parra Raul Jr. 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
MMSI CFO Raul Parra Receives RSUs, Surrenders Shares for Taxes
What Happened
Raul Parra Jr., Chief Financial Officer and Treasurer of Merit Medical Systems, received a total of 38,920 stock awards on 02/26/2026 (three award entries: 12,305; 9,613; 17,002 shares) reported as grants (code A) at $0.00. To satisfy payroll and income tax withholding related to these awards, he surrendered 5,778 shares (code F) at a reported value of $78.02 per share, totaling approximately $450,800. No shares were sold on the open market.
Key Details
- Transaction date: 2026-02-26; Form 4 filed: 2026-03-02 (timely filing).
- Awards: 12,305; 9,613; and 17,002 RSU/PSU-related shares granted (total 38,920) reported at $0.00.
- Tax withholding: 5,778 shares surrendered at $78.02/share = $450,800 (no open-market sale).
- Ownership after transaction: not specified in the provided data (plan holdings referenced as of 02/26/2026).
- Footnotes: grants include restricted stock units (RSUs) with different vesting schedules (one vests in three equal annual installments; one vests in two equal installments on years 2 and 3). 17,002 shares were issued upon the Compensation Committee’s determination under performance stock units granted 02/28/2023. Other notes reference option vesting schedules and plan holdings.
- Transaction codes: A = Award/Grant, F = Payment of tax liability (withholding).
Context
RSUs and PSUs are contingent rights to receive shares upon vesting — these grants are compensation, not purchases, and often reflect routine equity compensation for executives. The surrender of shares to cover taxes is a standard withholding method (a cashless/stock-surrender for tax liability), not an open-market sale and therefore less informative about the insider’s market sentiment.
Insider Transaction Report
- Award
Common Stock, No Par Value
[F2]2026-02-26+12,305→ 36,506 total - Award
Common Stock, No Par Value
[F3]2026-02-26+9,613→ 46,119 total - Award
Common Stock, No Par Value
[F4]2026-02-26+17,002→ 63,121 total - Tax Payment
Common Stock, No Par Value
[F5]2026-02-26$78.02/sh−5,778$450,800→ 57,343 total
- 2,735(indirect: By 401(k))
Common Stock, No Par Value
[F1] - 9,070
Non-qualified stock options (right to buy)
[F6]Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (9,070 underlying) - 13,576
Non-qualified stock options (right to buy)
[F7]Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying)
Footnotes (7)
- [F1]Represents plan holdings as of 02/26/2026.
- [F2]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- [F3]Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- [F4]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.
- [F5]The Reporting Person surrendered 5,778 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.
- [F6]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
- [F7]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.